Apraclonidine
RxNorm 14845
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 14845 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: apraclonidine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Apraclonidine
(Atom ID: 375438)
PTPrescribable
Designated preferred name (PT):
Apraclonidine
(Atom ID: 2856468)
FNPrescribable
Full form of descriptor (FN):
Apraclonidine (substance)
(Atom ID: 2856469)
PTPrescribable
Designated preferred name (PT):
Apraclonidine-containing product
(Atom ID: 10796999)
FNPrescribable
Full form of descriptor (FN):
Product containing apraclonidine (medicinal product)
(Atom ID: 9723379)
Patient Education
Apraclonidine Ophthalmic
Apraclonidine 0.5% eye drops are used for the short-term treatment of glaucoma (a condition that can cause damage to the optic nerve and vision loss, usually due to increased pressure in the eye) in people who are taking other medications for this condition and still have increased pressure in the eye. Apraclonidine 1% eye drops are used to prevent or reduce increased pressure in the eye during and after certain types of laser eye surgery. Apraclonidine is in a class of medications called alpha-2-adrenergic agonists. It lowers the pressure in the eye by decreasing the amount of fluid produced within the eye.
[Learn More]
* Please review the disclaimer below.